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Tobacco smoking is an important risk factor for lung cancer, respiratory
diseases and cardiovascular diseases, among others. Moreover, smoking can
speed up the normal aging process of several tissues increasing the
biological age. Changes in methylation due to smoking have been
demonstrated at several loci across the genome, particularly in long-term
smokers (Figure 1). The most consistent association reported in different
populations has been decreased methylation in smokers in comparison with
non-smokers at the CpG cg05575921, located in the gene for the aryl
hydrocarbon receptor repressor (AHRR) located in chromosome 5 (Figure 2
and Figure 3).
We analyzed 88 participants in the PREDIMED PLUS-Valencia study. The
PREDIMED PLUS-Valencia study (located on the eastern Mediterranean
coast, Spain) is one of the field centers of the multi-center PREDIMED Plus
study, which is an ongoing trial. This RCT was registered at
https://doi.org/10.1186/ISRCTN89898870. Eligible participants, were
recruited from several primary care health facilities in the Valencia field
center, were community-dwelling adults (men, 55–75 years, women, 60–75
years) with a body-mass index (BMI) in the overweight or obesity range
((BMI) ≥ 27 and <40 kg/m2) and had at least three components of the
metabolic syndrome. In the Valencia field center, the total number of
randomized participants included in the PREDIMED Plus trial was 465. Here
we analyzed a subsample of the 88 participants (44 males and 44 females)
selected by smoking status and paired by gender. Smoking status was
assessed according to the WHO classification (including current smokers,
former smokers (including former smokers <1 year, from 1 to 5 years and
more than 5 years) and never smokers. These subjects were aged 55 to 75
years, mean age 64+/-5 years, all with metabolic syndrome.
Anthropometric variables were determined by trained staff and follow the
PREDIMED Plus operations protocol detailed in the study Web site
(http://www.predimedplus.com/). Weight and height were measured with
calibrated scales and a wall-mounted stadiometer, respectively. BMI was
calculated as the weight in kilograms divided by the height in meters
squared. Leisure-time physical activity was assessed using the validated
REGICOR questionnaire including questions to collect information on the
type of activity, frequency (number of days), and duration.
A 17-item screening questionnaire was used for assessing adherence to an
energy-restricted Mediterranean diet. Figure 8 shows the detailed questions
included in the 17-item screening questionnaire. Two categories: low (less
than 10 points in the 17-item score) and high (> =10 points)] for adherence
to Mediterranean diet were considered.
Figure 1: Tobacco smoking)
Despite the numerous studies examining changes in methylation at the
genome-wide level depending on the smoking behavior, very few studies
have examined the additional influence of the diet in modulating the
smoking effects on methylation.
Therefore our aim was to examine whether a higher adherence to a
Mediterranean diet (MedDiet) modulated the effect of smoking on genome-
wide methylation among older subjects with metabolic syndrome.
In conclusion, our results suggest that MedDiet could be an additional
modulator of the smoking effects on DNA-methylation. These are
preliminary results and more work has to be done increasing sample size
and focusing on the different foods of the Mediterranean diet in addition to
the global food pattern measured by the 17-item score.
Another consistent association has been found with coagulation factor II
(thrombin) receptor-like 3 (F2RL3, cg03636183). Hypomethylation of this
gene has been associated with smoking in several studies and in different
populations mimicking the AHRR effects (Figure 6 and Figure 7).
Methods
DNA isolation and epigenome-wide methylation analyses
DNA was isolated from blood. We performed genome-wide DNA
methylation (EWAS) using the Illumina Infinium 850K MethylationEPIC array.
Differential methylation (M-values) was statistically analyzed with Partek
Genomic Suite using ANCOVA models adjusted for potential confounders
including batch effect, age, BMI, diabetes and leukocyte counts, among
others. Analyses in the whole population and stratified by the
Mediterranean diet adherence level were carried out. Interaction terms
were also tested. Quality control was carried out..
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Several individual studies and meta-analysis in different populations have
reported a strong hypomethylation signal in the CpG cg05575921 locus
depending on the smoking status . Among these studies, we show specific
data in the REGICOR study, a population study carried out in the
Mediterranean population (Figure 4), as well as the participants in the MESA
study (Figure 5).
Figure 8: Questions included in the 17-item questionnaire for
adherence to Mediterranean diet
Figure 4: Methylation of the
AHRR gene and other genes
depending on the smoking
status in the REGICOR study
(Epigenetics, 2015).
Figure 5: EWAS for
methylation status





of the AHRR and F2RL3
locus by smoking (Fasanelli
et al, Nat Comunications,
2015).
Figure 9: Methylation analysis
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Figure 2: AhRR, a specific
competitive repressor of aryl
hydrocarbon receptor (AhR)
activity based on its ability to
dimerize with the AhR nuclear
translocator (ARNT) and through
direct competition of AhR/ARNT
and AhRR/ARNT complexes
(Vogel et al, Current Opinion in
Toxicology, 2017).Figure 3: Location of the cg05575921
in the AHRR gene
Figure 6: Hypomethylation
of the AHRR and F2RL3
locus by smoking (Lee et al,
PlosOne, 2017).
Mean age of the participants was 64.6+/-5 years, without statistically
significant differences between men and women (P=0.236).
Mean BMI was 32.1+/-3.5 kg/m2 with no statistically significant differences
between men and women. Mediterranean diet adherence did not differed
by sex, being a mean of 8.4+/-3 points in the 17-item score screener.
There were 11% of current smokers, 3.3% former smokers of less than 1
year, 5.5% former smokers 1-5 years, 32% former smokers >5 years and 47%
never smokers.
In the EWAS carried out in the whole population, tobacco smoking was
associated with methylation of several genes (even after adjustment for
batch effect, sex, age, body mass index, diabetes, and leukocyte counts). The
top ranked CpG being: cg05575921-AHRR (P=1.57E-09); cg21566642
(P=4.12E-09); cg17739917-RARA (P=7.73E-08); cg01940273 (P=2.68E-07)
and cg03636183-F2RL3 (P=1.34E-06).
We observed a statistically significant hypomethylation of the well-known
maker of tobacco smoking, the cg05575921-AHRR in current smokers in
comparison with never smokers and even with former smokers.
Likely, we observed a similar methylation of the other well-known marker,
the cg03636183-F2RL3 locus. On the other hand, adherence to MedDiet
[two categories: low (less than 10 points in the 17-item score) and high (>
=10 points)] was associated with differential methylation of several genes
and some heterogeneity by smoking was detected.
Moreover, in the stratified analyses of the smoking effect on DNA
methylation depending on the MedDiet adherence group, several
differences were detected. Thus, in subjects with low adherence to
MedDiet, the top-ranked CpG associated with tobacco smoking were
cg05575921-AHRR (P=8.91E-07) and cg17739917-RARA (P=2.48E-06).
However, in subjects with high MedDiet adherence, some of the op-ranked
SNPs differed, indicating an additional modulation by the MedDiet.
Specifically, in subjects with high adherence to the MedDiet, the
cg05575921-AHRR was not among the 500 top-ranked SNPs, decreasing
differences in methylation (P=0.0058).
Conclusions
